Supplementary Figure S8 from Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047

Key Points

• Gene signatures were characterized based on treatment arms NIVO + RELA versus NIVO alone, revealing distinct profiles.
• Responses categorized as complete response/partial response and progressive disease were analyzed for differences.
• Data indicates possible stratification of patients based on gene expression linked to treatment response.
• Insights from biomarker analyses may inform future therapeutic strategies for patients with advanced melanoma.